2.14

2.73% -0.06

After Hours: 2.14

Akoya Biosciences Inc (AKYA)

Overview News Price History Option Chain Financials Discussions Forecast

Akoya Biosciences Inc stock is traded at $2.14, with a volume of 135.02K. It is down -2.73% in the last 24 hours and down -23.57% over the past month. Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.

Previous Close:

$2.20

Open:

$2.21

24h Volume:

135.02K

Relative Volume:

0.89

Market Cap:

$109.04M

Revenue:

$96.63M

Net Income/Loss:

$-63.32M

P/E Ratio:

-1.0863

EPS:

-1.97

Net Cash Flow:

$-54.55M

1W Performance:

-0.93%

1M Performance:

-23.57%

6M Performance:

+8.91%

1Y Performance:

-52.97%

1-Day Range:

$2.11

$2.26

1-Week Range:

$2.055

$2.35

52-Week Range:

$1.88

$6.31

Akoya Biosciences Inc Stock (AKYA) Company Profile

Name

Akoya Biosciences Inc

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

855.896.8401

Address

100 CAMPUS DRIVE, MARLBOROUGH

Employee

330

Twitter

Next Earnings Date

2024-11-14

Latest SEC Filings

AKYA's Discussions on Twitter

Compare AKYA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AKYA Akoya Biosciences Inc	2.14	109.04M	96.63M	-63.32M	-54.55M	-1.97
ISRG Intuitive Surgical Inc	538.55	192.83B	7.87B	2.24B	586.00M	4.25
BDX Becton Dickinson Co	221.98	64.77B	20.18B	1.73B	3.07B	5.51
ALC Alcon Inc	88.23	43.75B	9.76B	1.16B	665.00M	0.72
RMD Resmed Inc	249.33	36.84B	4.81B	1.11B	1.35B	6.16
WST West Pharmaceutical Services Inc	323.32	23.33B	2.88B	499.60M	321.60M	7.41

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Downgrade	Craig Hallum	Buy → Hold
Aug-06-24	Downgrade	BTIG Research	Buy → Neutral
Aug-06-24	Downgrade	JP Morgan	Overweight → Neutral
Aug-06-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-21-24	Initiated	Craig Hallum	Buy
Dec-14-23	Initiated	Guggenheim	Neutral
Jul-05-23	Resumed	JP Morgan	Overweight
Feb-02-23	Initiated	UBS	Buy
Nov-03-22	Initiated	CapitalOne	Overweight
Oct-06-22	Initiated	Stephens	Overweight
Jun-22-22	Initiated	BTIG Research	Buy
Jan-06-22	Resumed	Piper Sandler	Overweight
May-11-21	Initiated	Canaccord Genuity	Buy
May-11-21	Initiated	JP Morgan	Overweight
May-11-21	Initiated	Morgan Stanley	Overweight
May-11-21	Initiated	Piper Sandler	Overweight

View All

Akoya Biosciences Inc Stock (AKYA) Latest News

Nov 21, 2024

Piper Sandler Reiterates “Overweight” Rating for Akoya Biosciences (NASDAQ:AKYA) - Defense World

Nov 21, 2024

Nov 20, 2024

Akoya Biosciences stock target cut, rating held on recent earnings report - Investing.com Canada

Nov 20, 2024

Nov 19, 2024

Akoya Biosciences' (AKYA) Overweight Rating Reiterated at Piper Sandler - MarketBeat

Nov 19, 2024

Revenue Downgrade: Here's What Analysts Forecast For Akoya Biosciences, Inc. (NASDAQ:AKYA) - Simply Wall St

Nov 19, 2024

Nov 17, 2024

Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook - Yahoo Finance

Nov 17, 2024

Canaccord Genuity Group Issues Pessimistic Forecast for Akoya Biosciences (NASDAQ:AKYA) Stock Price - Defense World

Nov 17, 2024

Nov 16, 2024

Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 16, 2024

Nov 15, 2024

Akoya Biosciences shares target cut, maintains buy rating on Q3 results - Investing.com

Nov 15, 2024

Craig-Hallum Downgrades Akoya Biosciences (AKYA) - MSN

Nov 15, 2024

Akoya stock plunges 30% on outlook as Craig-Hallum cuts to hold - MSN

Nov 15, 2024

Akoya stock plunges 30% on outlook as Craig-Hallum cuts to hold (NASDAQ:AKYA) - Seeking Alpha

Nov 15, 2024

Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $3.50 by Analysts at Canaccord Genuity Group - MarketBeat

Nov 15, 2024

Akoya Biosciences (NASDAQ:AKYA) Stock Rating Lowered by Craig Hallum - MarketBeat

Nov 15, 2024

Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Akoya Biosciences Shares Sink After FY24 Outlook Cut - MarketWatch

Nov 15, 2024

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 20.8% in October - MarketBeat

Nov 15, 2024

Akoya Biosciences, Inc. Revises Earnings Guidance for the Full Year 2024 - Marketscreener.com

Nov 15, 2024

Akoya: Q3 Earnings Snapshot - Darien Times

Nov 15, 2024

Nov 14, 2024

Akoya Biosciences Reports Q3 2024 Financial Results - TipRanks

Nov 14, 2024

Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 14, 2024

Akoya Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 14, 2024

Akoya Biosciences earnings missed, revenue fell short of estimates By Investing.com - Investing.com Nigeria

Nov 14, 2024

Nov 13, 2024